Active · per the CBE, 31 October 2026

PHARMAD

BE0537770077

Rechtspersoon Private limited company 1 establishment

PHARMAD is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 29 August 2013, 1 establishment.

Ommegangstraat(Z) 4, 8550 Zwevegem

Behind the company: Adelinde Dierick, Mattias Thuysbaert.

Active for

13 year, 2 months

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

  • Tight liquidity NBB

    Cash and receivables cover 14 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMAD from Zwevegem, company number BE0537770077, closed financial year 2025 with a result of € 144,837 after tax. For that financial year PHARMAD recorded a gross margin of € 216,697 and equity of € 20,000. Compared with financial year 2024, the result moved from € 127,539 to € 144,837. Profitable, and profit is growing. The buffer shrank hard: equity is 96 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on January 27, 2026.

What it is worth Shrank hard

€ 20,000

▼ 96% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 144,837

▲ 14% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 8,325

▼ 87% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 688,233 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

0

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 21,086

▼ 39% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 10 years to go

€ 118,281

▼ 9% vs 2024

€ 11,521 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 1,325

▼ 61% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 24,705

▲ 18% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 151,918 € 221,128 € 190,568 € 216,697 ▲ 14%
Profit after taxes € 95,760 € 146,571 € 127,539 € 144,837 ▲ 14%
Equity € 590,952 € 437,523 € 563,396 € 20,000 ▼ 96%
Total debts € 491,997 € 625,291 € 460,978 € 1,028,512 ▲ 123%
Cash € 63,252 € 8,798 € 61,902 € 8,325 ▼ 87%
Retained profit € 570,952 € 417,523 € 543,396 € 0 ▼ 100%
Dividend € 30,000 € 300,000 € 1,666 € 688,233 ▲ € 686,567
Bank debt € 188,181 € 155,082 € 129,715 € 118,281 ▼ 9%
Balance sheet total € 1,082,950 € 1,062,814 € 1,024,374 € 1,048,512 ▲ 2%

Key figures of PHARMAD, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.

What happened to PHARMAD?

What happened at PHARMAD in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 144,837 (▲ 14% vs 2024). Source: NBB ↗
  • New establishment in Zwevegem. KBO
  • Start of the company according to the CBE. KBO
  • Adelinde Dierick became a director. NBB
  • Mattias Thuysbaert became a director. NBB

In short

From € 95,760 profit in 2022 to € 144,837 profit in 2025.

Paid € 167,623 in corporate taxes since 2022.

Best year ever: 2023, with € 146,571 profit.

Paid out € 1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Adelinde Dierick
Mattias Thuysbaert
PHARMAD
Adelinde Dierick bv 99.9%

Behind PHARMAD are Adelinde Dierick and Mattias Thuysbaert. It owns 99.9% of Adelinde Dierick bv itself.

Directors

According to the 2025 annual accounts

Adelinde Dierick

Director

since 2013

Mattias Thuysbaert

Director

since 2013

Establishments

Establishment units

Physical locations of this company

Registered office

Ommegangstraat(Z) 4

8550 Zwevegem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

PHARMA SERVICES ZWEVEGEM

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number
0537.770.077
VAT number
BE 0537.770.077
Registered office
Ommegangstraat(Z) 4, 8550 Zwevegem
Names & denominations
PHARMAD
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
29 August 2013
Peppol
Active · Active since 15 Oct 2025
Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

Frequently asked questions

What does PHARMAD do?
PHARMAD is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 29 August 2013, 1 establishment.
What is the address of PHARMAD?
The registered office of PHARMAD is located at Ommegangstraat(Z) 4, 8550 Zwevegem.
Is PHARMAD still active?
Yes. According to the CBE (31 October 2026) PHARMAD is active, legal situation “Normale toestand”, started on 29 August 2013.
Is PHARMAD registered on Peppol?
Yes, PHARMAD is registered on the Peppol network with ID 0208:0537770077.
What is the enterprise number of PHARMAD?
The enterprise number of PHARMAD is BE0537770077.
When was PHARMAD founded?
PHARMAD was founded on 29 August 2013.